optical coherence tomography angiography

Evaluating Aflibercept With Reduced-Fluence Photodynamic Therapy in Polypoidal Choroidal Vasculopathy: Insights from Longitudinal OCT Angiography

By MedXY 10/09/2026

This randomized trial compares aflibercept monotherapy versus combined with reduced-fluence photodynamic therapy for PCV, highlighting OCTA metrics that predict polypoidal lesion closure and treatment response over 52 weeks.

Neurology news Ophthalmology

Retinal OCTA as a Window into Cerebral Small Vessel Disease and Cognitive Decline Post-Stroke

By MedXY 09/20/2026

This longitudinal study shows that retinal microvascular changes measured by OCTA correspond with cerebral small vessel disease progression and cognitive decline in mild ischemic stroke patients, highlighting OCTA's potential as a noninvasive biomarker for brain vascular health.